ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

Technology Transfer Is Theme For 1990s, Broder Tells Writers; Laszio Offers Predictions On Treatment Advances

April 6, 1990